Item 8.01 Other Information

Timothy R. Wright, MiMedx Chief Executive Officer, and Dr. Robert B. Stein, President, Regenerative Medicine and Biologics Innovation, are expected to attend a fireside chat at the H.C. Wainwright Global Investment Conference in Miami, Florida on behalf of MiMedx Group, Inc. (the "Company"), on May 24, 2022 beginning at 10 a.m. Eastern Time. A copy of the presentation materials they will refer to is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this "Current Report") and is incorporated herein by reference.

The information in this Current Report, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.

Exhibit No.       Description of Exhibit

99.1                Slide Presentation dated May 24, 2022

104               The cover page from this Current Report on Form 8-K, formatted in
                  Inline XBRL.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses